The Vancouver, Canada-based biotech firm SaNOtize Research and Development Corporation has delivered on its intent for an India-based alliance, now sewing up an exclusive long-term deal with Glenmark Pharmaceuticals Limited to manufacture, market and distribute its novel Nitric Oxide Nasal Spray (NONS) for COVID-19.
Glenmark will commercialize NONS in India and certain other Asian markets including Singapore, Malaysia, Hong Kong, Taiwan, Nepal, Brunei, Cambodia,...





![Spotlight On RDCs, AOCs As Leading Novel Bioconjugates[Updated]](https://web.insights.norstella-labs.com/resizer/v2/3M7ZAWZOBNK7NG4A4WDOIFG6DU.jpg?smart=true&auth=392a1fdb3cfacb29445720c412410e598dbcc5f90f14857652cd498bd0faa0fb&width=400&height=225)
